Acacia Subsidiary Enters into Agreement with Sharp Corporation
Founded in 1993, Acacia Research Corporation is the industry leader in patent licensing .
Insider Selling: CombiMatrix Director Sells $27,358 in Stock
CombiMatrix Director R Judd Jessup unloaded 13,679 shares of the company's stock on the open market in a transaction dated Wednesday, August 13th.
Insider Selling: CombiMatrix Director Sells 13,679 Shares of Stock
CombiMatrix Director R Judd Jessup sold 13,679 shares of CombiMatrix stock in a transaction that occurred on Wednesday, August 13th.
CombiMatrix Turns In Another Record Quarter, Stock Remains Undervalued
Management continues to deliver on strategy focused on growth of prenatal microarray platform which generates highest revenue per test and holds most potential for long-term growth.
CombiMatrix's (CBMX) CEO Mark McDonough on Q2 2014 Results - Earnings Call Transcript
Greetings, and welcome to the CombiMatrix Corporation Second Quarter 2014 Financial Results Conference Call.
Laboratory Network .com
CombiMatrix's SNP-Based Miscarriage Analysis Test Granted...
CombiMatrix Corporation , a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that its SNP-based chromosomal microarray analysis test for miscarriage analysis, the CombiSNP Array for Pregnancy Loss, or products of conception, has received conditional approval from ... (more)
Amazon Slips On Wider-Than-Expected Loss; Acacia Research Shares Gain
Midway through trading Friday, the Dow traded down 0.80 percent to 16,947.71 while the NASDAQ tumbled 0.70 percent to 4,440.96.
Acacia Research Reports Second Quarter Financial Results and Announces Payment of Quarterly Dividend
Revenues in the second quarter of 2014 were $50,076,000, as compared to $23,110,000 in the comparable prior year quarter.